A carregar...
Medication Development for Agitation and Aggression in Alzheimer Disease: Review and Discussion of Recent Randomized Clinical Trial Design
BACKGROUND: The management of disruptive neuropsychiatric symptom (NPS) such as agitation and aggression (A/A) is a major priority in caring for people with Alzheimer’s disease (AD). Few effective pharmacological or non-pharmacological options are available. Results of randomized clinical trials (RC...
Na minha lista:
| Publicado no: | Int Psychogeriatr |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362786/ https://ncbi.nlm.nih.gov/pubmed/25226218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1041610214001720 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|